P1.12-02 Phase II Study of Amrubicin Monotherapy in Elderly or Poor-Risk Patients with Extensive Disease of Small Cell Lung Cancer
2018 ◽
Vol 13
(10)
◽
pp. S573
S. Igawa
◽
T. Fukui
◽
M. Shirasawa
◽
T. Ozawa
◽
H. Sone
◽
...
2017 ◽
Vol 35
(5)
◽
pp. 642-648
◽
Satoshi Igawa
◽
Sakiko Otani
◽
Shinichiro Ryuge
◽
Tomoya Fukui
◽
Yoshiro Nakahara
◽
...
2002 ◽
Vol 64
◽
pp. S254-S255
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7207-7207
◽
U. Lassen
◽
M. Sørensen
◽
P. B. Jensen
◽
S. W. Langer
◽
B. B. Jensen
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7265-7265
W. Koester
◽
G. Stamatis
◽
N. Niederle
◽
A. Heider
◽
K. Avramidis
◽
...
2008 ◽
Vol 26
(15_suppl)
◽
pp. 19078-19078
T. Mio
◽
M. Kawahara
◽
H. Yoshioka
◽
K. Yanagihara
◽
T. Daimon
◽
...
2000 ◽
Vol 29
(1)
◽
pp. 50
◽
R Gervais
◽
E Quoix
◽
K Mattson
◽
F.M Schramel
◽
A Rivière
◽
...
2008 ◽
Vol 2008
◽
pp. 199-200
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7216-7216
R. Pirker
◽
E. Ulsperger
◽
K. Aigner
◽
J. Messner
2008 ◽
Vol 26
(15_suppl)
◽
pp. 8093-8093
J. Han
◽
K. Lim
◽
S. Yoon
◽
H. Kim
◽
J. Han
◽
...
2018 ◽
Vol 36
(15_suppl)
◽
pp. 8575-8575
◽
YuJung Kim
◽
Bhumsuk Keam
◽
Chan-Young Ock
◽
Sanghoon Song
◽
Miso Kim
◽
...